BIDMC begins heart care research
Beth Israel Deaconess Medical Center has launched a new research center to evaluate and transform care for cardiovascular conditions.
The Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology will bring together clinicians and researchers to examine the most pressing challenges in cardiovascular care. They will examine clinical effectiveness, cost, quality, ethics and public policy.
The center's funding is part of a generous gift to BIDMC from Richard A. and Susan F. Smith.
Robert W. Yeh, MD will lead the center as director. A national leader in cardiovascular outcomes research and an interventional cardiologist specializing in complex coronary interventions, Yeh joins BIDMC from Massachusetts General Hospital.
"Rising health care costs, expanding technological capabilities and increasing patient complexity all impact the cardiovascular care delivered in the United States today," Peter Zimetbaum, MD, associate chief and clinical director of cardiology at the CardioVascular Institute at BIDMC and associate professor of medicine at Harvard Medical School, said in a news release.
[See also: OpenNotes showing benefits at BIDMC.]
The center will seek evidence-based insights that have the potential to dramatically improve patient outcomes, he added.
"Through clinical trials and data analysis, our researchers will assess clinical practices, therapies and devices used to treat the full range of cardiovascular conditions," said Yeh in a statement. "The engagement of physician-scientists in this new center will inform the clinical care offered by the CardioVascular Institute at Beth Israel Deaconess Medical Center and allow our patients to benefit quickly from new insights."
Yeh has led seminal research using electronic health record data to inform cardiovascular epidemiology and improve clinical risk prediction to maximize procedural value. He is recognized as an expert in the use of observational research methods in examining comparative effectiveness and evaluating health policy. In addition to his leadership of the Smith Center, he will maintain a clinical cardiology practice at the CardioVascular Institute at BIDMC and will continue to serve as medical director of trial design at the Harvard Clinical Research Institute.
[See also: The athenahealth/BIDMC collaboration.]